One of the primary challenges in developing antidotes is the vast number of potential toxins, each requiring specific solutions. Furthermore, the pharmacokinetics and pharmacodynamics of antidotes can be complex, and they must be tailored to act swiftly in emergencies. Regulatory challenges also exist, as the approval process for antidotes can be lengthy and complex.
